Cyclophosphamide as a first-line therapy in LGL leukemia

por Moignet, A, Hasanali, Z, Zambello, R, Pavan, L, Bareau, B, Tournilhac, O, Roussel, M, Fest, T, Awwad, A, Baab, K, Semenzato, G, Houot, R, Loughran, T P, Lamy, T
Publicado 2014

P955: CARFILZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: THE REAL-LIFE EXPERIENCE OF EMMY

por Hulin, C., Macro, M., Perrot, A., Royer, B., Caillot, D., Belhadj, K., Frenzel, L., Benramdane, R., Demarquette, H., Bareau, B., Darre, S., Calmettes, C., Le Calloch, R., Bouketouche, M., Laribi, K., Texier, N., Willaime, M., Deal, C., Moreau, P., Decaux, O.
Publicado 2022

P891: IXAZOMIB, POMALIDOMIDE AND DEXAMETHASONE (IXPD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) CHARACTERIZED WITH HIGH-RISK CYTOGENETICS. IFM 2014-01

por Bobin, A., Manier, S., De Keizer, J., Karlin, L., Perrot, A., Hulin, C., Caillot, D., Mariette, C., Lenain, P., Richez, V., Tiab, M., Touzeau, C., Jaccard, A., Decaux, O., Araujo, C., Belhadj, K., Benboubker, L., Déal, C., Macro, M., Vincent, L., Arnulf, B., Bareau, B., Braun, T., Calmettes, C., mamoun, D., Zerazhi, H., Demarquette, H., Feugier, P., Fohrer-sonntag, C., Godet, S., Petillon, M.-O., Avet-Loiseau, H., Leleu, X.
Publicado 2022